%First Table: Part 1
\begin{landscape}
\begin{table}[p]
\scriptsize
\centering
\caption[Autophagy modulation as a therapy in in vitro models of neurodegenerative diseases]{Autophagy modulation as a therapy in in vitro models of neurodegenerative diseases}
\label{tab:table1}
\begin{tabular}{lcccccc}

\toprule
& Autophagy modulators & FDA-approved & Disease model & Mutant protein & Brain region (cell type) & \textbf{cont.}\\
\midrule
\multirow{3}{*}{mTOR dependent} & \multirow{3}{*}{Rapamycin} & \multirow{3}{*}{Yes} & \multirow{3}{*}{AD} & Tau\textsubscript{P301L} & COS-7 & \textbf{1}\\
& & & & APP751/7PA22 & \makecell{Chinese hamster \\ ovary cells (7PA2 cells)} & \textbf{2} \\\cmidrule[0.5pt]{2-7}
& Temsirolimus (CCI-779) & Yes & AD & APP\textsubscript{695} & HEK 293 cells & \textbf{3} \\

\midrule
\multirow{13}{*}{mToR independent}& \multirow{4}{*}{Cilostazol} & \multirow{4}{*}{Yes} & \multirow{4}{*}{AD} & APP\textsubscript{695} & \multirow{4}{*}{N2a cells} & \multirow{4}{*}{\textbf{4}} \\
& & & & A$\beta$\textsubscript{1- 42} & & \\
& & & & Retinoic acid & \\
& & & & APP\textsubscript{695} & \\\cmidrule{2-7}
& Resveratrol & Yes & AD & A$\beta$\textsubscript{1- 42} & N2a cells & \textbf{5} \\\cmidrule{2-7}
& \multirow{2}{*}{Trehalose} & \multirow{2}{*}{Yes} & Taupathy & Tau\textsubscript{rd}$\Delta$K280 & N2a cells & \textbf{6} \\
& & & AD & A$\beta$40 \& 42 & SH-SY-5Y & \textbf{7} \\\cmidrule{2-7}
& \multirow{4}{*}{Rilmenidine} & \multirow{4}{*}{Yes} & HD & htt & PC12 & \textbf{8} \\
& & & PD & $\alpha$-synuclein  & PC12 &\textbf{9} \\
& & & HD & htt & SK-N-SH & \textbf{10} \\ 
& & & ALS & SOD1A4V &  NSC-34 cells & \textbf{11} \\\cmidrule{2-7}
& \multirow{4}{*}{SMER28} & \multirow{4}{*}{Yes} & \multirow{4}{*}{AD} & CTF$\beta$ & MEF cells & \textbf{12} \\\cmidrule{5-7}
& & & & \multirow{3}{*}{APP\textsubscript{695}} & N2a cells & \textbf{13} \\
& & & & & MEF cells & \textbf{14} \\
& & & & & N2a cells & \textbf{15} \\

\bottomrule
\end{tabular}
\end{table}
\end{landscape}

%First Table: Part 2
\begin{landscape}
\begin{table}[p]
\scriptsize
\centering
\caption*{Autophagy modulation as a therapy in in vitro models of neurodegenerative diseases \textit{(continued)}}

\begin{tabular}{cccccccc}

\toprule
\textbf{cont.} & Dose & Duration & Basal flux & \makecell{Induced flux \\inhibition} & \makecell{Assessment for \\ aggregation} & \makecell{Assessment for \\ autophagy} & References \\
\midrule
\textbf{1} & 0.2 $\mu$g/ml & 48 h & - & 3MA & WB (Tau) & - & \citet{Berger2006} \\\cmidrule{2-7}
\textbf{2} & 0.5, 5 \& 50 $\mu$g/ml & 24 h & - & - & Elisa (A$\beta$42) & - & \citet{Caccamo2010} \\\cmidrule{1-8}
\textbf{3} & 100 nM & 24 h & - & - & \makecell{WB (APP, C99 \& C88) \\ \& Elisa (A$\beta$40/42)} & WB (LC3II \& p62) & \citet{Jiang2014a} \\\cmidrule{1-8}
\textbf{4} & 10 $\mu$M & - & - & - & \makecell{Elisa (A$\beta$40/42) \& \\ FM (APP-CTF$\beta$)} & FM (LC3 II) & \citet{Park2016} \\\cmidrule{1-8}
\multirow{6}{*}{\textbf{5}} & 3, 10 \& 30 $\mu$M & 3 h& - & - & - & WB (beclin 1, ATG5) & \multirow{6}{*}{\citet{Lee2015}} \\\cmidrule{2-7}
 & 10 $\mu$M & \multirow{4}{*}{3 h} & - & 3 MA & - & WB (LC3 II) &  \\
 & 10 $\mu$M \& 30 $\mu$M & & - & - & \makecell{Elisa (A$\beta$1-42) \& \\ WB (APP-CTF$\beta$ \& A$\beta$)} & WB (beclin 1, ATG5) \\
 & 20 $\mu$M & & - & - & - & WB (beclin 1, ATG5) \\\cmidrule{1-8}
\multirow{4}{*}{\textbf{6}} & 12.5, 25 \& 50 mM & 24 h & - & - & - & WB (LC3 II) & \multirow{4}{*}{\citet{Kruger2012}} \\\cmidrule{2-7}
 & \multirow{3}{*}{50 mM} & 12, 24, 48 \& 72 h & - & - & - & WB (LC3 II) \\\cmidrule{3-7}
 & & \multirow{2}{*}{24 h} & - & - & FM \& WB (Tau) & FM (LC3) \\
 & & & BafA1 & BafA1 & - & WB (LC3 II) \\\cmidrule{1-8}
\textbf{7} & 1, 10 \& 50 mM & 12 h & - & - & FM (A$\beta$40 \& 42) & - & \citet{Liu2005} \\\cmidrule{1-8}
\textbf{8} & \multirow{4}{*}{1 $\mu$M} & \multirow{2}{*}{24 h} & - & - & - & WB (LC3 II) & \citet{Rose2010} \\\cmidrule{4-8}\cmidrule{1-1}
\textbf{9} & & & - & - & WB ($\alpha$-synuclein ) & WB (LC3 II) & \multirow{3}{*}{\citet{Williams2008}} \\\cmidrule{3-7}\cmidrule{1-1}
\multirow{2}{*}{\textbf{10}} & & 48 h & - & - & WB (ï»¿EGFP-HDQ74) & - \\\cmidrule{2-2}
 & 0.3, 1 \& 3 $\mu$M & 24 h & - & - & - & WB (LC3 II) \\\cmidrule{1-8}
\textbf{11} & 10 $\mu$M & 24 h & BafA1 & BafA1 & - & WB (LC3 II) & \multirow{2}{*}{\citet{Perera2018}} \\\cmidrule{1-7}
\multirow{2}{*}{\textbf{12}} & \multirow{2}{*}{10 $\mu$M} & \multirow{2}{*}{16 h} & - & - & WB (SOD1) & WB (LC3 II \& p62) \\\cmidrule{8-8}
& & & - & - & WB (CTF$\beta$) & - & \\\cmidrule{1-7}
\multirow{3}{*}{\textbf{13}} & 3, 10, 30 \& 50 $\mu$M & & - & - & \makecell{WB (APP-CTF \& \\ APP-FL)} & - & \\\cmidrule{4-7}
 & 50 $\mu$M & 6 h & - & - & \multirow{2}{*}{\makecell{Elisa (A$\beta$1-42) \& \\ WB (APP-CTF \& APP-FL)}} & WB (LC3 II) &  \citet{Tian2011} \\
 & & & BafA1 & BafA1 & & - \\\cmidrule{1-2}\cmidrule{4-7}
\textbf{14} & 1, 3, 10, 30 \& 50 $\mu$M & & - & - &  WB (APP-CTF) & - \\\cmidrule{1-2}\cmidrule{4-7}
\textbf{15} & 50 $\mu$ & & - & - & \makecell{WB (APP-CTF) \& \\ FM (APP \& APP-CTF)} & \makecell{WB (LC3 II) \& \\ FM (EGFP-LC3)}\\

\bottomrule
\end{tabular}
\end{table}
\end{landscape}